OSCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Oscar Health Inc (OSCR) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong membership growth, improving financial performance, and positive analyst sentiment indicate a favorable long-term outlook. Despite the overbought RSI and lack of immediate trading signals, the company's position in the growing healthcare sector and its innovative ACA market model make it a solid investment opportunity.
The MACD is positive at 0.425, indicating bullish momentum, but it is contracting. RSI is overbought at 81.685, suggesting the stock may be overextended in the short term. Moving averages are converging, showing potential consolidation. Key resistance is at 15.643, with support at 12.075.
Membership growth to 3.4 million during the 2026 open enrollment period, showcasing strong performance in the ACA market.
Healthcare sector projected to grow significantly due to rising healthcare spending and an aging population.
Analysts see the company's margins recovering and view it as an attractive investment at current levels.
RSI indicates overbought conditions, which could lead to short-term price corrections.
Lack of immediate trading signals from AI Stock Picker and SwingMax.
In Q4 2025, revenue increased by 17.30% YoY to $2.81 billion. Net income improved significantly, up 129.64% YoY, though still negative at -$352.61 million. EPS improved by 100% YoY to -1.24. Gross margin remained flat at 0%.
Raymond James upgraded the stock to Outperform with an $18 price target, citing attractive valuation and margin recovery. UBS lowered the price target to $15 but maintained a Neutral rating.
